Last reviewed · How we verify

NCT04786860

The Success Rate of Cardiopulmonary Resuscitation in Patients Experiencing In-hospital Cardiac Arrest

Completed Last updated 16 April 2024
What this trial tests

trial testing CPR in Cardiac Arrest, Sudden in 415 participants. Completed in 31 December 2022.

Timeline
1 November 2021
Primary endpoint
30 November 2022
31 December 2022

Quick facts

Lead sponsorUdayana University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment415
Start date1 November 2021
Primary completion30 November 2022
Estimated completion31 December 2022
Sites2 locations across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Udayana University

Who can join

18 and older, any sex, with Cardiac Arrest, Sudden or Cardiopulmonary Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac arrest causes the heart to stop functioning to maintain circulation that provides oxygen to the brain. The global incidence of cardiac arrest is 50 to 60 per 100,000 people per year. The incidence of cardiac arrest in Indonesia in 2016 was 350,000 cases, in which 12% were successfully resuscitated, compared to the global success rate of 24.8%. Cardiac arrest events urgently require CPR action that is useful to save lives in an emergency. The application of Code Blue aims to reduce the mortality rate and increase the rate of return of spontaneous circulation. The Code Blue team itself includes a set of teams who are trained in the handling of cardiorespiratory arrest.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of CPR

Trials testing the same drug.

Other recruiting trials for Cardiac Arrest, Sudden

Currently open trials in the same condition.

Other Udayana University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04786860.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing